目的:通过临床药师参与1例感染性心内膜炎抗感染治疗期间华法林剂量调整的药学实践,探讨其在临床治疗中发挥的作用.方法:临床药师依靠药学知识尤其是药动学优势,抗菌药物治疗期间与医师一起共同参与药物治疗监测及制定华法林给药剂量方案.结果:经过反复调整华法林剂量,最终达到满意抗凝目标值.结论:临床药师参与临床治疗实践,有利于提高药物治疗水平.Objective:To explore the role of clinical pharmacists in clinical treatment by adjusting the dose of warfarin during the period of anti-infective treatment in a patient with infective endocarditis.Methods: The clinical pharmacists collaborated with clinicians monitored drug therapy and adjusted the dose of warfarin during the period of anti-infective treatment utilizing their pharmaceutical knowledge, especially pharmacokinetic knowledge.Results:After repeatedly adjusted the dose of warfrin, and eventually reached a satisfactory target value of anticoagulation.Conclusion: Cli...
Almost precisely a century ago, in the 1920s and 1930s, cattle bled to death in North America after ...
Background: The cephalosporin class has been associated with an increased risk of bleeding among eld...
Warfarin is an anticoagulant medication that is used for the prevention and treatment of...
目的:分析和总结华法林与抗肿瘤药物和相关辅助药物的相互作用,为临床安全用药提供参考.方法:采用回顾性分析的方法,通过医院信息管理系统调取2006年1月-2015年12月我院住院患者使用华法林的医嘱,提...
Warfarin is an oral anticoagulant that is indicated for the prevention and treatment of various card...
1例82岁女性房颤患者,服用华法林治疗2年余,INR控制在1.5~2.5,因肺部感染,合用氟康唑及头孢哌酮/舒巴坦钠等药物,用药后第4天,INR升至12.28,咯血.分析出血原因,建议立即停用华法林、...
IMPORTANCE: The effect of antibiotic coadministration on the international normalized ratio (INR) in...
目的:探讨不同的随访方式对苄丙酮香豆素钠抗凝疗效的影响.方法:106例口服苄丙酮香豆素钠抗凝治疗的非瓣膜性房颤患者,随机分为专人负责的随访组和普通门诊的随访组,进行1年的治疗和观察,记录INR值和出血...
目的:结合基因型检测为患者提供合理的华法林个体化抗凝治疗。方法通过参与1例因心房颤动发作、肺部感染加重、心功能不全的老年女性患者抗凝治疗过程,分析国际标准化比值(INR)升高的原因,结合基因型结果(C...
Several groups of antibiotics are known to interact with warfarin, presenting a challenge to the pre...
Background: The cephalosporin class has been associated with an increased risk of bleeding among eld...
Warfarin therapy is associated with many drug interactions that may cause a significant alteration i...
目的:研究合并用药、病理因素等对华法林住院患者治疗的影响。方法收集我院心内科应用华法林的住院患者病历共136份,统计分析治疗相关指标、不良反应与华法合并用药、住院期间病理状态等的相关性。结果与结论莫西...
Contains fulltext : 202664.pdf (Publisher’s version ) (Closed access)Warfarin is d...
新型抗凝药物的研发是近年来心血管疾病治疗中最活跃的部分,但是华法林作为最古老的口服抗凝药物仍然是需要长期抗凝治疗患者的最常用药物,例如静脉血栓栓塞性疾病、心房颤动血栓栓塞的预防、瓣膜病和瓣膜置换术后,...
Almost precisely a century ago, in the 1920s and 1930s, cattle bled to death in North America after ...
Background: The cephalosporin class has been associated with an increased risk of bleeding among eld...
Warfarin is an anticoagulant medication that is used for the prevention and treatment of...
目的:分析和总结华法林与抗肿瘤药物和相关辅助药物的相互作用,为临床安全用药提供参考.方法:采用回顾性分析的方法,通过医院信息管理系统调取2006年1月-2015年12月我院住院患者使用华法林的医嘱,提...
Warfarin is an oral anticoagulant that is indicated for the prevention and treatment of various card...
1例82岁女性房颤患者,服用华法林治疗2年余,INR控制在1.5~2.5,因肺部感染,合用氟康唑及头孢哌酮/舒巴坦钠等药物,用药后第4天,INR升至12.28,咯血.分析出血原因,建议立即停用华法林、...
IMPORTANCE: The effect of antibiotic coadministration on the international normalized ratio (INR) in...
目的:探讨不同的随访方式对苄丙酮香豆素钠抗凝疗效的影响.方法:106例口服苄丙酮香豆素钠抗凝治疗的非瓣膜性房颤患者,随机分为专人负责的随访组和普通门诊的随访组,进行1年的治疗和观察,记录INR值和出血...
目的:结合基因型检测为患者提供合理的华法林个体化抗凝治疗。方法通过参与1例因心房颤动发作、肺部感染加重、心功能不全的老年女性患者抗凝治疗过程,分析国际标准化比值(INR)升高的原因,结合基因型结果(C...
Several groups of antibiotics are known to interact with warfarin, presenting a challenge to the pre...
Background: The cephalosporin class has been associated with an increased risk of bleeding among eld...
Warfarin therapy is associated with many drug interactions that may cause a significant alteration i...
目的:研究合并用药、病理因素等对华法林住院患者治疗的影响。方法收集我院心内科应用华法林的住院患者病历共136份,统计分析治疗相关指标、不良反应与华法合并用药、住院期间病理状态等的相关性。结果与结论莫西...
Contains fulltext : 202664.pdf (Publisher’s version ) (Closed access)Warfarin is d...
新型抗凝药物的研发是近年来心血管疾病治疗中最活跃的部分,但是华法林作为最古老的口服抗凝药物仍然是需要长期抗凝治疗患者的最常用药物,例如静脉血栓栓塞性疾病、心房颤动血栓栓塞的预防、瓣膜病和瓣膜置换术后,...
Almost precisely a century ago, in the 1920s and 1930s, cattle bled to death in North America after ...
Background: The cephalosporin class has been associated with an increased risk of bleeding among eld...
Warfarin is an anticoagulant medication that is used for the prevention and treatment of...